Ingersoll Rand (NYSE:IR) Board Member Julie Schertell Resigns From Key Committees

Simply Wall St.
03-29

Last week, Ingersoll Rand experienced a period of stability as the resignation of Julie A. Schertell from its Board of Directors marked a governance shift. While this executive change was a potential catalyst, the company’s performance coincided with broader market trends influenced by economic concerns triggered by a hot inflation reading and weak consumer sentiment, causing index declines. The Dow Jones fell 1.7%, and the S&P 500 slid 2%, reflecting investors’ cautious stance amid rising inflation expectations. Ingersoll Rand's share price held steady, weathering the economic climate alongside other market participants.

Buy, Hold or Sell Ingersoll Rand? View our complete analysis and fair value estimate and you decide.

NYSE:IR Revenue & Expenses Breakdown as at Mar 2025

Find companies with promising cash flow potential yet trading below their fair value.

In the last five years, Ingersoll Rand's total shareholder return has been significant, increasing by 254.40%. This impressive growth can be attributed to the company's active mergers and acquisitions strategy, including the acquisition of ILC Dover, which played a key role in revenue expansion. In addition, the firm's commitment to sustainability and corporate accolades from the Dow Jones Best-in-Class Indices and the CDP A List have likely enhanced brand value and customer loyalty, supporting shareholder returns.

Ingersoll Rand also implemented a substantial share buyback program, repurchasing approximately 12.3 million shares, which may have contributed to the favorable total return outcome. Furthermore, earnings reports consistently showed incremental annual growth, such as Q4 2024 sales reaching US$7.24 billion. Despite this growth record, the company underperformed relative to the US Machinery industry over the past year, which returned a 2.4% decline, indicating market volatility impacts.

Dive into the specifics of Ingersoll Rand here with our thorough balance sheet health report.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NYSE:IR.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10